The magnitude of weight gain and the proportion of adolescent patients who had clinically significant weight gain were greater with long-term exposure (at least 24 weeks) than with short-term exposure.
Kaalutõusu ulatus ning kliiniliselt olulise kaalutõusuga noorukieas patsientide suhe oli suurem pikaajalise avaldumise puhul (vähemalt 24 nädalat) kui lühiajalise avaldumise puhul.